Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C44H67N5O4 |
Molecular Weight | 730.0339 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC[C@@]3([H])[C@@]4(C)COC[C@@]3(C[C@H]([C@@H]4OC[C@](C)(N)C(C)(C)C)N5N=CN=C5C6=CC=NC=C6)C1=CC[C@@]7(C)[C@H](C(O)=O)[C@](C)(CC[C@]27C)[C@H](C)C(C)C
InChI
InChIKey=BODYFEUFKHPRCK-ZCZMVWJSSA-N
InChI=1S/C44H67N5O4/c1-27(2)28(3)39(7)18-19-41(9)30-12-13-33-40(8)23-52-25-44(33,31(30)14-17-42(41,10)34(39)37(50)51)22-32(35(40)53-24-43(11,45)38(4,5)6)49-36(47-26-48-49)29-15-20-46-21-16-29/h14-16,20-21,26-28,30,32-35H,12-13,17-19,22-25,45H2,1-11H3,(H,50,51)/t28-,30+,32-,33+,34-,35+,39-,40-,41-,42+,43+,44+/m1/s1
MK-3118 is an orally active inhibitor of fungal β-(1,3)-glucan synthase patented by Merck Sharp & Dohme Corp for the treatment of fungal infections. MK-3118 demonstrated enhanced efficacy for most C. albicans and C. glabrata ER isolates relative to caspofungin. MK-3118 showed no or poor activity against Mucoromycotina and Fusarium spp. However, MK-3118 was highly active against Paecilomyces variotii and was the only compound displaying some activity against notoriously pan-resistant Scedosporium prolificans.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
519616
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
||
|
FDA ORPHAN DRUG |
531716
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
A92JFM5XNU
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
10597
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
DB12471
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
2560213
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
GH-40
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
A92JFM5XNU
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
C162185
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
DTXSID901336871
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
46871657
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
100000177832
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY | |||
|
1207753-03-4
Created by
admin on Sat Dec 16 07:57:37 GMT 2023 , Edited by admin on Sat Dec 16 07:57:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)